Hilpi Rautelin mainly investigates Microbiology, Helicobacter pylori, Internal medicine, Gastroenterology and Campylobacter jejuni. His Microbiology research is multidisciplinary, incorporating perspectives in Lactobacillus rhamnosus and Lactobacillus. The Helicobacter pylori study which covers Serology that intersects with Pathology and CagA.
His Internal medicine study combines topics from a wide range of disciplines, such as Probiotic and Immunology. Hilpi Rautelin focuses mostly in the field of Gastroenterology, narrowing it down to matters related to Amoxicillin and, in some cases, Clarithromycin, Clostridia, Anti-ulcer Agent, Minimum inhibitory concentration and Metronidazole. The study incorporates disciplines such as Outbreak, Campylobacter and Multilocus sequence typing, Genotype in addition to Campylobacter jejuni.
His scientific interests lie mostly in Microbiology, Helicobacter pylori, Internal medicine, Campylobacter jejuni and Immunology. His Microbiology research incorporates themes from Campylobacter and Gene, Virulence. His studies in Helicobacter pylori integrate themes in fields like Serology, Antibody and Seroprevalence.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Amoxicillin and Metronidazole. His work is dedicated to discovering how Gastroenterology, Probiotic are connected with Bifidobacterium breve and other disciplines. Hilpi Rautelin combines subjects such as Genotype, Multilocus sequence typing, Pulsed-field gel electrophoresis and Enteritis with his study of Campylobacter jejuni.
His primary areas of investigation include Microbiology, Campylobacter jejuni, Campylobacter, Virulence and Gene. His studies deal with areas such as Gut flora and Salmonella as well as Microbiology. His research in Campylobacter jejuni intersects with topics in Bacteremia, Multilocus sequence typing, Genotype and Enteritis.
Specifically, his work in Campylobacter is concerned with the study of Campylobacter coli. His biological study spans a wide range of topics, including Internal medicine and Helicobacter pylori. He interconnects Immunology and Toxicity in the investigation of issues within Gastroenterology.
Hilpi Rautelin mostly deals with Campylobacter, Campylobacter jejuni, Microbiology, Enteritis and Antimicrobial. He has included themes like Biotechnology and Environmental health in his Campylobacter study. The concepts of his Campylobacter jejuni study are interwoven with issues in Genome, Allele and Molecular epidemiology, Genotype.
Many of his studies on Microbiology involve topics that are commonly interrelated, such as Gut flora. His Enteritis study combines topics in areas such as Bacteremia, Campylobacter fetus and Drug resistance. Hilpi Rautelin has researched Campylobacter coli in several fields, including Campylobacteriosis, Biosecurity, Risk of infection, Flock and Disease burden.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Lactobacillus Bacteremia during a Rapid Increase in Probiotic Use of Lactobacillus rhamnosus GG in Finland
Minna K. Salminen;Soile Tynkkynen;Hilpi Rautelin;Maija Saxelin.
Clinical Infectious Diseases (2002)
Lactobacillus Bacteremia, Clinical Significance, and Patient Outcome, with Special Focus on Probiotic L. Rhamnosus GG
Minna K. Salminen;Hilpi Rautelin;Soile Tynkkynen;Tuija Poussa.
Clinical Infectious Diseases (2004)
Campylobacteriosis: the role of poultry meat.
C. P. A. Skarp;M-L Hanninen;Hilpi I Rautelin;Hilpi I Rautelin.
Clinical Microbiology and Infection (2016)
Detection and Typing of Campylobacter jejuni and Campylobacter coli and Analysis of Indicator Organisms in Three Waterborne Outbreaks in Finland
Marja-Liisa Hänninen;H. Haajanen;T. Pummi;K. Wermundsen.
Applied and Environmental Microbiology (2003)
Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy: a placebo-controlled, double-blind randomized pilot study
Eveliina Myllyluoma;Lea Veijola;Lea Veijola;T Ahlroos;Soile Tynkkynen.
Alimentary Pharmacology & Therapeutics (2005)
Lactobacilli and Bacteremia in Southern Finland, 1989–1992
M Saxelin;N H Chuang;B Chassy;H Rautelin.
Clinical Infectious Diseases (1996)
Swimming and Campylobacter infections.
Daniela Schönberg-Norio;Johanna Takkinen;Marja-Liisa Hänninen;Marja-Leena Katila.
Emerging Infectious Diseases (2004)
Age-dependent increase of Campylobacter pylori antibodies in blood donors.
T. U. Kosunen;J. Höök;H. I. Rautelin;G. Myllylä.
Scandinavian Journal of Gastroenterology (1989)
Role of metronidazole resistance in therapy of Helicobacter pylori infections.
H Rautelin;K Seppälä;O V Renkonen;U Vainio.
Antimicrobial Agents and Chemotherapy (1992)
Lactobacillus Bacteremia, Species Identification, and Antimicrobial Susceptibility of 85 Blood Isolates
M. K. Salminen;H. Rautelin;H. Rautelin;S. Tynkkynen;T. Poussa.
Clinical Infectious Diseases (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: